Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

13.76
Delayed Data
As of Apr 24
 -0.18 / -1.29%
Today’s Change
7.09
Today|||52-Week Range
14.07
+65.78%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 11.00. The median estimate represents a +1.74% increase from the last price of 13.76.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.01
Sales
$29.2M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -113.33%
 
 
 
 
 
 
Growthannually -62.50%
 
 
 
 
 
 

Sales

Growthquarterly -5.34%
 
 
 
 
 
 
Growthannually 13.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account